RSS

IMBRUVICA

Supplier in chemical development and manufacturing Lonza has established an agreement with Pharmacyclics, Inc. to support the commercial and clinical production of its oral oncology drug IMBRUVICA (Ibrutinib). This agreement follows a successful... more

Technology